THE EFFICACY AND SAFETY OF LEBRIKIZUMAB PLUS TOPICAL CORTICOSTEDOIDS IN MODERATETO SEVERE ATOPIC DERMATITIS. CDF. 2024;53(03):6987-6993. doi:10.48047/vwmbcr61